The Maryland Stem Cell Research Commission, the body overseeing The Maryland Stem Cell Research Fund (MSCRF), has awarded Nanochon grant funding to support its manufacturing capabilities. Nanochon relocated to The Launchport, in Baltimore Maryland last year in order to prepare for manufacturing scale-up for its upcoming pivotal trial and increase access to valuable resources that the Maryland ecosystem provides, such as expertise in medical device manufacturing, commercialization and funding.
“The Launchport has created a supportive environment for us to network with local partners and has provided us with guidance to accelerate our development.” said Ben Holmes, CEO and Co-founder of Nanochon. “We are very fortunate to have the opportunity to land at such a welcoming space and be able to take advantage of the fantastic experienced resources in Baltimore.”
The Launchport is a manufacturing accelerator located in Baltimore’s Port Covington area and provides medical device start-ups and emerging technology developers the ability to co-locate at an experienced, regulated medical device manufacturing center. The site is ISO 13485 certified and offers ample space for the core capabilities necessary for Nanochon: engineering space, sterilization and clean rooms, and 3D printing technologies.
MSCRF is an independent program within TEDCO, Maryland’s Technology Development Corporation, and awarded nondilutive grants to 11 projects in its first funding round of fiscal year 2026. Awards were divided between three categories: launch, commercialization and manufacturing assistance, of which Nanochon was one of just two companies awarded the later. The program offers assistance to nascent companies who are located in Maryland and are focused on cutting-edge research and innovation in the field of regenerative medicine.